BA
CRTX

BlackRock Advisors’s CORNERSTONE THERAPEUTICS INC CRTX Stock Holding History

BlackRock Advisors’s Portfolio CRTX Stock Details CRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-4,237
Closed -$40K – 3685
2013
Q4 		$40K Buy
4,237
+159
+4% +$1.51K ﹤0.01% 3283
2013
Q3 		$38K Buy
4,078
+160
+4% +$1.44K ﹤0.01% 3241
2013
Q2 		$31K Buy
+3,918
New +$33K ﹤0.01% 3230

Other funds holding CRTX

AA
Ancora Advisors Cleveland, Ohio $5.19B AUM 23.19% 1-Year Est. Return

BlackRock Advisors's CRTX Position: Q1 2014 in Review

BlackRock Advisors sold out of CORNERSTONE THERAPEUTICS INC (CRTX) in Q1 2014, closing a stake of 4,237 shares — an estimated $40K sold.

BlackRock Advisors first reported a position in CRTX in Q2 2013 and held it in 3 quarters. The position peaked at $40K in Q4 2013. 1 fund tracked by Wall St. Rank holds CRTX as of Q1 2014.

  • BlackRock Advisors reported no remaining CORNERSTONE THERAPEUTICS INC position as of Q1 2014 after selling out during the quarter.
  • BlackRock Advisors sold 4,237 CORNERSTONE THERAPEUTICS INC shares in Q1 2014, an estimated $40K.
  • BlackRock Advisors first reported a position in CORNERSTONE THERAPEUTICS INC in Q2 2013 and held it in 3 quarters.
  • BlackRock Advisors's CORNERSTONE THERAPEUTICS INC position peaked at $40K in Q4 2013.
  • 1 fund tracked by Wall St. Rank held CORNERSTONE THERAPEUTICS INC as of Q1 2014.

Based on BlackRock Advisors's 13F filing for Q1 2014, filed 2 May 2014.